HEPA
HEPION PHARMACEUTICALS, INC.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q2 2025 | Q3 2025 | — | +0% |
| Renaissance Technologies | Q4 2024 | Q2 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Hepion Pharmaceuticals, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 27, 2026 — the most recent Form 4 on file — not from today.
- Form 40001493152-26-019202Apr 27, 2026
- Form 40001493152-26-019029Apr 27, 2026
- Form 40001493152-26-019028Apr 27, 2026
- Form 40001493152-26-019027Apr 27, 2026
- Form 40001493152-24-009215Mar 7, 2024
- Form 40001493152-24-007465Feb 21, 2024
- Form 40001493152-24-007462Feb 21, 2024
- Form 40001493152-24-007464Feb 21, 2024
- Form 40001493152-24-007463Feb 21, 2024
- Form 40001104659-23-121427Nov 28, 2023
- Form 40001104659-23-102209Sep 20, 2023
- Form 40001104659-23-101784Sep 19, 2023
- Form 40001104659-23-101391Sep 18, 2023
- Form 40001104659-21-070074May 20, 2021
- Form 40001104659-21-069942May 20, 2021
Fundamentals
XBRL · HEPION PHARMACEUTICALS, INC.Annual figures sourced directly from HEPION PHARMACEUTICALS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Hepion Pharmaceuticals, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportMay 14, 2026
- DEF 14AProxy statementApr 28, 2026
- 8-KMaterial eventApr 22, 2026
- 8-KMaterial eventApr 14, 2026
- 8-KMaterial eventMar 18, 2026
- 10-KAnnual reportMar 12, 2026
- 8-KMaterial eventMar 3, 2026
- 8-KMaterial eventJan 15, 2026
- 10-QQuarterly reportNov 12, 2025
- 10-QQuarterly reportAug 14, 2025
- 8-KMaterial eventJun 30, 2025
- 8-KMaterial eventJun 12, 2025
- 8-KMaterial eventJun 9, 2025
- 8-KMaterial eventMay 30, 2025
- 10-QQuarterly reportMay 19, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q4 2024 | Q1 2025 | $0.00 | — | +0% |
| Renaissance Technologies | Q4 2024 | Q2 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.